Nicole M. Verrills

New Lambton Heights
New Lambton, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Effects of Inhibitors of the Activity of the Circulating Renin-Angiotensin System on the Growth and Proliferation of Endometrial Cancer Cells.

Effects of Inhibitors of the Activity of the Circulating Renin-Angiotensin System on the Growth and Proliferation of Endometrial Cancer Cells.

Journal: International journal of molecular sciences
Published: October 14, 2025

Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity.

Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity.

Journal: Molecular cancer therapeutics
Published: April 01, 2025

Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for acute myeloid leukemia cell self-renewal.

Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for acute myeloid leukemia cell self-renewal.

Journal: Leukemia
Published: February 10, 2025

Proteogenomic profiling of acute myeloid leukemia to identify therapeutic targets.

Proteogenomic profiling of acute myeloid leukemia to identify therapeutic targets.

Journal: Expert review of proteomics
Published: November 22, 2024

Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics.

Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics.

Journal: Pharmacology & therapeutics
Published: October 21, 2024

Phosphoproteomic analysis of the adaption of epididymal epithelial cells to corticosterone challenge.

Phosphoproteomic analysis of the adaption of epididymal epithelial cells to corticosterone challenge.

Journal: Andrology
Published: August 16, 2023

Pharmaco-phosphoproteomic analysis of cancer-associated KIT mutations D816V and V560G.

Pharmaco-phosphoproteomic analysis of cancer-associated KIT mutations D816V and V560G.

Journal: Proteomics
Published: August 14, 2023

Proteomic and phosphoproteomic characterisation of primary mouse embryonic fibroblasts.

Proteomic and phosphoproteomic characterisation of primary mouse embryonic fibroblasts.

Journal: Proteomics
Published: June 30, 2023

The impact of a regionally based translational cancer research collaborative in Australia using the FAIT methodology.

The impact of a regionally based translational cancer research collaborative in Australia using the FAIT methodology.

Journal: BMC health services research
Published: April 20, 2023

Correction to: Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection.

Correction to: Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection.

Journal: Clinical proteomics
Published: April 08, 2023

Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies.

Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies.

Journal: Science signaling
Published: March 28, 2023

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.

Journal: The Journal of clinical investigation
Published: March 08, 2023
Showing 1-12 of 51

Last Updated: 09/26/2026